GB1202148A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1202148A
GB1202148A GB1095768A GB1095768A GB1202148A GB 1202148 A GB1202148 A GB 1202148A GB 1095768 A GB1095768 A GB 1095768A GB 1095768 A GB1095768 A GB 1095768A GB 1202148 A GB1202148 A GB 1202148A
Authority
GB
United Kingdom
Prior art keywords
active ingredient
pharmaceutical compositions
comprise
compositions
thebainol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1095768A
Inventor
Isao Seki
Hiromu Takagi
Shinsaku Kobayashi
Issei Iwai
Haruhiko Minakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to GB1095768A priority Critical patent/GB1202148A/en
Publication of GB1202148A publication Critical patent/GB1202148A/en
Application status is Expired legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine

Abstract

1,202,148. Antitussives. SANKYO CO. Ltd. 6 March, 1968. No. 10957/68. Heading A5B. Antitussive pharmaceutical compositions comprise 14-hydroxy-dihydro-6-beta-thebainol- 4-methyl ether as active ingredient and comprise a sterile solution syrup or suspension for oral administration, a pressurised composition containing a liquified propellant or the active ingredient in admixture with a solid pharmaceutical carrier or diluent. The compositions may be administered orally as tablets optionally coated, powders, capsules or granules and the sterile solutions optionally contain preservatives and antibacterial agents.
GB1095768A 1968-03-06 1968-03-06 Pharmaceutical compositions Expired GB1202148A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1095768A GB1202148A (en) 1968-03-06 1968-03-06 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1095768A GB1202148A (en) 1968-03-06 1968-03-06 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1202148A true GB1202148A (en) 1970-08-12

Family

ID=9977425

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1095768A Expired GB1202148A (en) 1968-03-06 1968-03-06 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB1202148A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306575A1 (en) * 1987-09-10 1989-03-15 The University Of Chicago Quaternary derivatives of noroxymorphone which relieve nausea and emesis
US8003794B2 (en) 2005-05-25 2011-08-23 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US8247425B2 (en) 2008-09-30 2012-08-21 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8338446B2 (en) 2007-03-29 2012-12-25 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8343992B2 (en) 2005-05-25 2013-01-01 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US8471022B2 (en) 2008-02-06 2013-06-25 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
US8552025B2 (en) 2003-04-08 2013-10-08 Progenics Pharmaceuticals, Inc. Stable methylnaltrexone preparation
US9102680B2 (en) 2007-03-29 2015-08-11 Wyeth Llc Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306575A1 (en) * 1987-09-10 1989-03-15 The University Of Chicago Quaternary derivatives of noroxymorphone which relieve nausea and emesis
US9669096B2 (en) 2003-04-08 2017-06-06 Progenics Pharmaceuticals, Inc. Stable pharmaceutical formulations of methylnaltrexone
US8552025B2 (en) 2003-04-08 2013-10-08 Progenics Pharmaceuticals, Inc. Stable methylnaltrexone preparation
US8003794B2 (en) 2005-05-25 2011-08-23 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US8343992B2 (en) 2005-05-25 2013-01-01 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US8916581B2 (en) 2005-05-25 2014-12-23 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US9597327B2 (en) 2005-05-25 2017-03-21 Progenics Pharmaceuticals, Inc. Synthesis of (R)-N-methylnaltrexone
US8853232B2 (en) 2007-03-29 2014-10-07 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US9102680B2 (en) 2007-03-29 2015-08-11 Wyeth Llc Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
US8338446B2 (en) 2007-03-29 2012-12-25 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8772310B2 (en) 2007-03-29 2014-07-08 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US9879024B2 (en) 2007-03-29 2018-01-30 Progenics Pharmaceuticals., Inc. Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
US8471022B2 (en) 2008-02-06 2013-06-25 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US8916706B2 (en) 2008-02-06 2014-12-23 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US8455644B2 (en) 2008-09-30 2013-06-04 Wyeth Peripheral opioid receptor antagonists and uses thereof
US9180125B2 (en) 2008-09-30 2015-11-10 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US9492445B2 (en) 2008-09-30 2016-11-15 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US8420663B2 (en) 2008-09-30 2013-04-16 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8247425B2 (en) 2008-09-30 2012-08-21 Wyeth Peripheral opioid receptor antagonists and uses thereof
US9724343B2 (en) 2008-09-30 2017-08-08 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US8822490B2 (en) 2008-09-30 2014-09-02 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof

Similar Documents

Publication Publication Date Title
CA954858A (en) Pyridyl oxadiazole derivatives and process for the preparation thereof and pharmaceutical compositions containing same
IL31246D0 (en) Phenylethanolamines,their preparation and pharmaceutical and veterinary compositions containing them
GB1161439A (en) Pharmaceutical Compositions
JO1502B1 (en) Novel pharmacological compounds
CA2023630A1 (en) Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
IL60723A (en) 4-benzyl-and 4-benzoyl-imidazole derivatives,pharmaceutical compositions containing the same and their preparation
EP0395329A3 (en) composition in the form of a foam containing 5-aminosalicylic acid for intra-rectal administration
SG52784G (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa,and method for administration thereof
IL67572A (en) Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them
MY7400329A (en) Drug for use in pharmaceutical composition
IL89748A (en) Pharmaceutical compositions for systemic transdermal administration, containing deprenyl
CA2117351A1 (en) Preparation of Tablets of Increased Strength
IL43762D0 (en) Novel 11,11-alkylidene-steroids,their preparation and pharmaceutical compositions containing them
AU2430871A (en) Crushing and dispensing container for administering pills
KE3030A (en) Aryloxyalkanolamine derivatives,their preparation and use in pharmaceutical compositions
IL36237A (en) Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them
ZA7101189B (en) 1-(1,3,4-thiadiazol-2-yl)-imidazolidinone-(2)derivatives,process for their preparation and their use as herbicidal agents
IL38364A (en) 8-azapurin-6-one derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HK19481A (en) 3,4-dihydrocarbostyril derivatives,their preparation,and pharmaceutical compositions thereof
IL31146D0 (en) 1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-diones,their preparation and pharmaceutical compositions containing them
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
EP0555898A3 (en) Medicaments for non-topical use
CA928296A (en) N-substituted and n, n-disubstituted aminocarbonylalkyl compounds and their production
GR3017773T3 (en) Composition of an active agent for oral administration, especially to ruminants.

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee